Purdue Pharma has agreed to pay $270 million to settle a lawsuit brought by Oklahoma that claimed it used deceptive marketing tactics to increase sales of opioid drugs, contributing to the state’s
Care standards and ethics in the NHS are once again under scrutiny after a report found that overprescription of opiates at Gosport War Memorial Hospital shortened hundreds of lives.
Eisai and Biogen have their second regulatory approval for anti-amyloid therapy Leqembi – in Japan – as a treatment for slowing the progression of Alzheimer’s disease.
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho